The effect of
quercetin was assessed in rats induced with complete
Freund adjuvant (CFA).
Arthritis scores, paw oedema, latency, activities of
myeloperoxidase (MPO), ectonucleoside
triphosphate diphosphohydrolase (E-NTPDase), and ectoadenosine deaminase (E-ADA) in lymphocytes were determined. Furthermore,
nucleotide and
nucleoside levels as well as the secretion of pro- and anti-inflammatory
cytokines were evaluated. Animals were treated with saline and
quercetin in doses of 5, 25, and 50 mg/kg for 45 days. The result revealed that
quercetin (50 mg/kg) reduced
arthritis score and paw oedema, and increased the latency in the
thermal hyperalgesia test. Histopathological analysis showed that all the doses of
quercetin reduced infiltration of inflammatory cells. MPO activity was increased in the
arthritis group; however,
quercetin reduced this activity. E-NTPDase activity was increased in lymphocytes of
arthritis rats, and treatment with
quercetin reversed this increase. However, E-ADA activity was reduced in the
arthritis group, and treatment with
quercetin modulated the activity of this
enzyme in
arthritis rat groups. Serum
adenosine levels were increased in
arthritis, and the levels were lowered with
quercetin treatment.
Quercetin treatment in
arthritis groups decreased the elevated levels of
cytokines in the
arthritis control group. Thus,
quercetin demonstrated an anti-inflammatory effect, and this
flavonoid may be a promising natural compound for the treatment of
arthritis. SIGNIFICANCE OF THE STUDY:
Quercetin may represent a potential therapeutic compound in the treatment of
rheumatoid arthritis. Findings from this study indicate that
quercetin suppresses swelling and attenuates the underlying inflammatory responses. This is the first report where
quercetin was shown to modulate the immune response to
arthritis via attenuation of the purinergic system (E-NTPDase and E-ADA activities) and the levels of IFN-gamma and
IL-4. Thus, this work is relevant to basic research and may be translated into clinical practice.